세계의 혈액형 타이핑 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2033년)

Global Blood Group Typing Market size is anticipated to grow from USD 2.14 Billion in 2024 to USD 4.74 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 9.3% during the forecast period of 2026 to 2033.

The blood group typing market is set for substantial growth, driven by the increasing demand for accurate blood typing in transfusion medicine, organ transplantation, and prenatal testing. As the global population continues to expand, the need for safe and effective blood transfusions becomes paramount, necessitating reliable blood group typing methods to prevent transfusion reactions and ensure patient safety. The rise in surgical procedures and the growing prevalence of blood disorders are further propelling the demand for advanced blood typing technologies, making this market a critical component of modern healthcare.

Technological advancements in blood typing methodologies are enhancing the accuracy and efficiency of testing processes. Innovations such as molecular typing techniques and automated blood typing systems are streamlining workflows in laboratories, reducing turnaround times and minimizing human error. Additionally, the integration of digital health solutions, including electronic health records and laboratory information systems, is facilitating seamless data management and improving the overall efficiency of blood typing services. As these technologies continue to evolve, the market is expected to witness a surge in the adoption of rapid and precise blood typing solutions across various healthcare settings, including hospitals, blood banks, and diagnostic laboratories.

Moreover, the blood group typing market will benefit from the increasing focus on personalized medicine and the need for tailored treatment approaches. As healthcare providers recognize the importance of understanding individual blood types in managing various medical conditions, the demand for comprehensive blood typing services will rise. Public health initiatives aimed at promoting blood donation and improving transfusion safety will also drive the market, as awareness of the critical role of accurate blood typing in emergency situations grows. Collaborative efforts between healthcare organizations, regulatory bodies, and technology developers will be essential in advancing blood typing methodologies and ensuring their widespread implementation.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product

• Instruments
• Reagents & Kits

By Test Type

• ABO Tests
• Antigen Typing
• Antibody Screening
• Cross-matching Tests
• HLA Typing

By Technique

• Serology Tests
• Molecular Tests

By End-User

• Hospital-based Laboratories
• Independent Laboratories
• Blood Banks
• COMPANIES PROFILED
• Quotient Limited
• CareDx Inc.
• Agena Bioscience Inc. (Mesa Laboratories Inc.)
• DIAGAST Illumina Inc.
• Grifols
• S.A.
• Immucor Inc.
• Bio-Rad Laboratories Inc.
• Thermo Fisher Scientific Inc.
• Merck KGaA
• QIAGEN
• Beckman Coulter Inc.
• QuidelOrtho Corporation
• The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. BLOOD GROUP TYPING INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porters Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Technique
  • 3.7.3 Market Attractiveness Analysis By Test Type
  • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL BLOOD GROUP TYPING MARKET ANALYSIS BY PRODUCT

• 5.1. Overview By Product
• 5.2. Historical and Forecast Data
• 5.3. Analysis By Product
• 5.4. Consumables Historic and Forecast Sales By Regions
• 5.5. Instruments Historic and Forecast Sales By Regions
• 5.6. Services Historic and Forecast Sales By Regions

6. GLOBAL BLOOD GROUP TYPING MARKET ANALYSIS BY TECHNIQUE

• 6.1. Overview By Technique
• 6.2. Historical and Forecast Data
• 6.3. Analysis By Technique
• 6.4. PCR-based and Microarray Techniques Historic and Forecast Sales By Regions
• 6.5. Assay-based Techniques Historic and Forecast Sales By Regions
• 6.6. Massively Parallel Sequencing Techniques Historic and Forecast Sales By Regions
• 6.7. Other Techniques Historic and Forecast Sales By Regions

7. GLOBAL BLOOD GROUP TYPING MARKET ANALYSIS BY TEST TYPE

• 7.1. Overview By Test Type
• 7.2. Historical and Forecast Data
• 7.3. Analysis By Test Type
• 7.4. Antibody Screening Historic and Forecast Sales By Regions
• 7.5. HLA Typing Historic and Forecast Sales By Regions
• 7.6. Cross-matching Tests Historic and Forecast Sales By Regions
• 7.7. ABO Blood Tests Historic and Forecast Sales By Regions
• 7.8. Antigen Typing Historic and Forecast Sales By Regions

8. GLOBAL BLOOD GROUP TYPING MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2 North America By Segment Sales Analysis
  • 8.3.3 North America By Country Sales Analysis
  • 8.3.4 United States Sales Analysis
  • 8.3.5 Canada Sales Analysis
  • 8.3.6 Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2 Europe By Segment Sales Analysis
  • 8.4.3 Europe By Country Sales Analysis
  • 8.4.4 United Kingdom Sales Analysis
  • 8.4.5 France Sales Analysis
  • 8.4.6 Germany Sales Analysis
  • 8.4.7 Italy Sales Analysis
  • 8.4.8 Russia Sales Analysis
  • 8.4.9 Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2 Asia Pacific By Segment Sales Analysis
  • 8.5.3 Asia Pacific By Country Sales Analysis
  • 8.5.4 China Sales Analysis
  • 8.5.5 India Sales Analysis
  • 8.5.6 Japan Sales Analysis
  • 8.5.7 South Korea Sales Analysis
  • 8.5.8 Australia Sales Analysis
  • 8.5.9 South East Asia Sales Analysis
  • 8.5.10 Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2 Latin America By Segment Sales Analysis
  • 8.6.3 Latin America By Country Sales Analysis
  • 8.6.4 Brazil Sales Analysis
  • 8.6.5 Argentina Sales Analysis
  • 8.6.6 Peru Sales Analysis
  • 8.6.7 Chile Sales Analysis
  • 8.6.8 Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2 Middle East & Africa By Segment Sales Analysis
  • 8.7.3 Middle East & Africa By Country Sales Analysis
  • 8.7.4 Saudi Arabia Sales Analysis
  • 8.7.5 UAE Sales Analysis
  • 8.7.6 Israel Sales Analysis
  • 8.7.7 South Africa Sales Analysis
  • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE BLOOD GROUP TYPING COMPANIES

• 9.1. Blood Group Typing Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10. COMPANY PROFILES OF BLOOD GROUP TYPING INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Grifols
  • 10.3.1 Company Overview
  • 10.3.2 Company Revenue
  • 10.3.3 Products
  • 10.3.4 Recent Developments
• 10.4. S.A.
  • 10.4.1 Company Overview
  • 10.4.2 Company Revenue
  • 10.4.3 Products
  • 10.4.4 Recent Developments
• 10.5. Merck KGaA
  • 10.5.1 Company Overview
  • 10.5.2 Company Revenue
  • 10.5.3 Products
  • 10.5.4 Recent Developments
• 10.6. Bio-Rad Laboratories Inc.
  • 10.6.1 Company Overview
  • 10.6.2 Company Revenue
  • 10.6.3 Products
  • 10.6.4 Recent Developments
• 10.7. Immucor Inc.
  • 10.7.1 Company Overview
  • 10.7.2 Company Revenue
  • 10.7.3 Products
  • 10.7.4 Recent Developments
• 10.8. Novacyt Group
  • 10.8.1 Company Overview
  • 10.8.2 Company Revenue
  • 10.8.3 Products
  • 10.8.4 Recent Developments
• 10.9. Danaher Corporation
  • 10.9.1 Company Overview
  • 10.9.2 Company Revenue
  • 10.9.3 Products
  • 10.9.4 Recent Developments
• 10.10. Agena Bioscience Inc.
  • 10.10.1 Company Overview
  • 10.10.2 Company Revenue
  • 10.10.3 Products
  • 10.10.4 Recent Developments
• 10.11. Ortho Clinical Diagnostics
  • 10.11.1 Company Overview
  • 10.11.2 Company Revenue
  • 10.11.3 Products
  • 10.11.4 Recent Developments
• 10.12. Quotient Ltd
  • 10.12.1 Company Overview
  • 10.12.2 Company Revenue
  • 10.12.3 Products
  • 10.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies